[go: up one dir, main page]

SG43432A1 - Anti-stress composition - Google Patents

Anti-stress composition

Info

Publication number
SG43432A1
SG43432A1 SG1996010929A SG1996010929A SG43432A1 SG 43432 A1 SG43432 A1 SG 43432A1 SG 1996010929 A SG1996010929 A SG 1996010929A SG 1996010929 A SG1996010929 A SG 1996010929A SG 43432 A1 SG43432 A1 SG 43432A1
Authority
SG
Singapore
Prior art keywords
stress composition
stress
composition
Prior art date
Application number
SG1996010929A
Other languages
English (en)
Inventor
Sumio Asami
Zhi-Bo Yang
Eiji Yamashita
Original Assignee
Suntory Ltd
Itano Refrigerated Food Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd, Itano Refrigerated Food Co Ltd filed Critical Suntory Ltd
Publication of SG43432A1 publication Critical patent/SG43432A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
SG1996010929A 1995-10-26 1996-10-25 Anti-stress composition SG43432A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7279225A JPH09124470A (ja) 1995-10-26 1995-10-26 抗ストレス組成物

Publications (1)

Publication Number Publication Date
SG43432A1 true SG43432A1 (en) 1997-10-17

Family

ID=17608180

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996010929A SG43432A1 (en) 1995-10-26 1996-10-25 Anti-stress composition

Country Status (7)

Country Link
US (1) US6265450B1 (ja)
EP (1) EP0770385A1 (ja)
JP (1) JPH09124470A (ja)
KR (1) KR970020098A (ja)
AU (1) AU725308B2 (ja)
NZ (1) NZ299641A (ja)
SG (1) SG43432A1 (ja)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE522246C2 (sv) * 1997-02-27 2004-01-27 Astacarotene Ab Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion
SE512531C2 (sv) * 1997-09-04 2000-03-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur
SE511237C2 (sv) * 1997-12-16 1999-08-30 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
SE524337C2 (sv) 1998-10-16 2004-07-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
IL129442A0 (en) * 1999-04-14 2000-02-29 Lycored Natural Prod Ind Ltd Compounds useful in reducing the level of insulin like growth factor-1 (IGF-1) in blood
NO309386B1 (no) * 1999-04-19 2001-01-22 Norsk Hydro As Pigment
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US8642051B2 (en) 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
SE0001071D0 (sv) * 2000-03-27 2000-03-27 Astacarotene Ab Method of inhibiting the expression of inflammatory cytokines and chemokines
US7078040B2 (en) * 2000-03-27 2006-07-18 Fuji Chemical Industry Co., Ltd. Method of inhibiting the expression of inflammatory cytokines and chemokines
CA2374958C (en) * 2000-05-16 2010-06-01 Suntory Limited Compositions normalizing circadian rhythm
IL141038A (en) * 2001-01-23 2006-10-05 Lycored Natural Prod Ind Ltd Use of carotenoids for the preparation of substances for the treatment of high blood pressure
JP4628557B2 (ja) * 2001-02-07 2011-02-09 末人 山上 血行障害の改善作用を有する健康補助食品
WO2002077105A1 (fr) * 2001-03-22 2002-10-03 Fuji Chemical Industry Co., Ltd. Compositions pulverulentes a base d'astaxanthine et procede de production associe
JP5041565B2 (ja) * 2001-05-25 2012-10-03 富士化学工業株式会社 安定なアスタキサンチンとγ−シクロデキストリンとの包接化合物及びその製造方法、並びに液剤、飲食物、飼料、医薬品及び化粧品用途
JP4859006B2 (ja) * 2001-05-25 2012-01-18 富士化学工業株式会社 安定なアスタキサンチン−シクロデキストリン包接化合物及びその製造方法、並びに該包接化合物を含有する液剤、飲食物、飼料、医薬品及び化粧品
WO2002102394A2 (en) * 2001-06-18 2002-12-27 Neptune Technologies & Bioressources Inc. Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
AU2002322233C1 (en) 2001-07-27 2014-02-13 Aker Biomarine Antarctic As Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
AU2003234765B2 (en) * 2002-04-30 2009-09-17 Suntory Holdings Limited Astaxanthin medium-chain fatty acid ester, process for producing the same and composition containing the ester
WO2004005353A1 (en) * 2002-07-04 2004-01-15 Poltec As Complexes of cyclodextrins and carotenoids
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US7320997B2 (en) 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7345091B2 (en) 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
EP1532108B1 (en) * 2002-07-29 2016-06-29 Cardax Pharma, Inc. Astaxanthin esters for the inhibition and amelioration of disease
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
GB0218932D0 (en) * 2002-08-14 2002-09-25 Zoolife Internat Ltd Composition for dietary enrichment
WO2004021798A1 (es) * 2002-09-03 2004-03-18 Centro De Investigacion En Alimentacion Y Desarrollo A.C. Metodo de preparacion de microcapsulas de astaxantina en quitosano y producto obtenido
US8034372B2 (en) * 2003-03-05 2011-10-11 Nestec, Ltd. Dietary supplement for athletic pets
WO2005011712A1 (en) * 2003-07-25 2005-02-10 Washington State University Research Foundation Natural astaxanthin extract reduces dna oxidation
JP4933097B2 (ja) * 2003-12-19 2012-05-16 株式会社メニコン 糖尿病および糖尿病合併症の治療・改善方法
US7691901B2 (en) * 2004-04-14 2010-04-06 Cardax Pharmaceuticals Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2005099479A1 (en) * 2004-04-16 2005-10-27 Nestec S.A. Methods and compositions for reducing oxidative stress in an animlal
EP1771091B1 (en) * 2004-07-01 2017-11-08 Nestec S.A. Canine osteoarthritis diet formulation
US7666447B2 (en) * 2004-10-08 2010-02-23 Pharmanutrients Compositions including Krill extracts and conjugated linoleic acid and methods of using same
JP2006176476A (ja) * 2004-12-24 2006-07-06 Joyaku Kenkyusho:Kk ヒメヒオウギズイセンの鱗茎を含有する腫瘍の予防及び／又は治療用組成物
JP2006008714A (ja) * 2005-03-17 2006-01-12 Yamaha Motor Co Ltd マトリックスメタロプロテイナーゼ阻害剤
JP2006008718A (ja) * 2005-06-03 2006-01-12 Yamaha Motor Co Ltd シクロオキシゲナーゼ活性阻害剤
JP2006008719A (ja) * 2005-06-23 2006-01-12 Yamaha Motor Co Ltd 血中過酸化脂質抑制剤
WO2007043046A2 (en) * 2005-10-11 2007-04-19 Lycored Ltd. Carotenoid oxidation products as chemopreventive and chemotherapeutic agents
US20070135521A1 (en) * 2005-12-14 2007-06-14 Yamaha Hatsudoki Kabushiki Kaisha Agent for Preventing Metabolic Syndrome
JP4564471B2 (ja) * 2006-07-06 2010-10-20 株式会社コーセー 外用に適する組成物
JP5071618B2 (ja) * 2006-11-17 2012-11-14 学校法人慶應義塾 外分泌腺の機能障害改善剤及び機能障害改善用飲食物
JP2008291150A (ja) * 2007-05-25 2008-12-04 Cyclochem:Kk アスタキサンチンーシクロデキストリン包接化合物
US20090118227A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
JP2009234926A (ja) * 2008-03-25 2009-10-15 Kinji Ishida 副腎肥大抑制剤及びそれを含有する飼料組成物又は治療用組成物
JP2009234924A (ja) * 2008-03-25 2009-10-15 Kinji Ishida 免疫回復剤及びそれを含有する飼料組成物
US8273380B1 (en) 2009-05-19 2012-09-25 Jetway Inc. Fortified beverage for minimizing and/or preventing jet lag
JP5497372B2 (ja) * 2009-08-19 2014-05-21 バイオジェニック株式会社 非ステロイド性抗炎症薬起因性潰瘍の予防・治療薬
RU2755902C2 (ru) 2009-10-29 2021-09-22 Акасти Фарма, Инк. Концентрированные терапевтические фосфолипидные композиции
JP2012025712A (ja) * 2010-07-27 2012-02-09 Jx Nippon Oil & Energy Corp 抗不安組成物
WO2012157290A1 (ja) * 2011-05-19 2012-11-22 富士化学工業株式会社 非アルコール性脂肪性肝炎の予防改善剤
US10328152B2 (en) 2011-06-16 2019-06-25 Nayan Patel Method for stabilization and delivery of therapeutic molecules
US20140127385A1 (en) * 2012-11-04 2014-05-08 Ingredient Innovations International Stable Aqueous Dispersions of Poorly Soluble Crystalline Nutrients
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
JP6071988B2 (ja) * 2014-12-09 2017-02-01 国立大学法人北海道大学 身体活動促進剤
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
EP3231421A1 (en) * 2016-04-11 2017-10-18 Greenaltech, S.L. Uses of a carotenoid in the treatment or prevention of stress induced conditions
JP7352237B2 (ja) 2018-02-02 2023-09-28 富士化学工業株式会社 腸内細菌叢中のアッカーマンシアを増やすためにアスタキサンチンを使用する方法及び医薬組成物
US11696593B2 (en) 2018-08-24 2023-07-11 Bioscience Formulators, LLC Astaxanthin nutritional compositions and uses
US20230226105A1 (en) * 2021-11-10 2023-07-20 Reverspah Llc Methods and compositions for treating cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998753A (en) 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
JPH01186860A (ja) 1988-01-14 1989-07-26 Kaiji Watanabe アスタキサンチン含有粉体の製造方法
JP2619491B2 (ja) * 1988-08-11 1997-06-11 サントリー株式会社 アスタキサンチン含有組成物
JPH0383577A (ja) 1989-08-28 1991-04-09 Dainippon Ink & Chem Inc 破砕藻体組成物、その製造法、食品、飼料、着色剤及び抗酸化剤
DK546289D0 (da) 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
CA2047000A1 (en) 1990-07-20 1992-01-21 John W. Chapman Astaxanthin-generating yeast cells
JPH05124958A (ja) * 1991-09-19 1993-05-21 Yukio Date 過酸化脂質低下作用を有する組成物
DE4141351A1 (de) 1991-12-14 1993-06-17 Basf Ag Stabile pulverfoermige vitamin- und/oder carotinoid-praeparate und verfahren zu deren herstellung
DK0565989T3 (da) 1992-04-14 1997-12-15 Hoffmann La Roche Præparater af fedtopløselige stoffer
JPH0665068A (ja) * 1992-08-11 1994-03-08 Suntory Ltd 抗ストレス組成物
IL110139A0 (en) 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
JPH0799925A (ja) 1993-09-30 1995-04-18 Food Design Gijutsu Kenkyu Kumiai 濃縮ファフィア色素油を含有する蛋白質性食品
JPH0799926A (ja) 1993-09-30 1995-04-18 Food Design Gijutsu Kenkyu Kumiai 濃縮ファフィア色素油を含有する水性液状食品
JPH0799924A (ja) 1993-09-30 1995-04-18 Nippon Suisan Kaisha Ltd アスタキサンチンを主要成分とするファフィア色素油の安定な粉末化物及びその製造方法
JPH0799888A (ja) 1993-09-30 1995-04-18 Food Design Gijutsu Kenkyu Kumiai 濃縮ファフィア色素油を含有する油脂及び油脂加工食品
JPH0799932A (ja) * 1993-09-30 1995-04-18 Nippon Suisan Kaisha Ltd ファフィア色素油を含有する健康食品
JP3266719B2 (ja) 1993-10-21 2002-03-18 株式会社クラレ アスタキサンチンの精製法

Also Published As

Publication number Publication date
NZ299641A (en) 2001-03-30
AU7040496A (en) 1997-05-01
EP0770385A1 (en) 1997-05-02
US6265450B1 (en) 2001-07-24
JPH09124470A (ja) 1997-05-13
AU725308B2 (en) 2000-10-12
KR970020098A (ko) 1997-05-28

Similar Documents

Publication Publication Date Title
SG43432A1 (en) Anti-stress composition
HUP9802544A3 (en) Cable-sheathing composition
EG20993A (en) Cleasing compositions
EG20989A (en) Cleasing compositions
GB9613043D0 (en) Improved compositions
EP0765916A3 (en) Hydrosilylation crosslinkable compositions
SG52651A1 (en) Composition
PL322571A1 (en) Deodoising composition
GB9518033D0 (en) Composition
EP0756827A3 (de) Präparat zur Ernährung
GB9500577D0 (en) Compositions
GB9504996D0 (en) Compositions
HU9600352D0 (en) Bitumenous composition
GB9516371D0 (en) Compositions
GB9524918D0 (en) Solid composition
GB9515805D0 (en) Compositions
GB9508323D0 (en) Composition
HUP9601550A2 (en) Particulale compositions
GB9604856D0 (en) Compositions
AP9600802A0 (en) Libricant
GB9511701D0 (en) Composition
GB9519109D0 (en) Compositions
GB9505885D0 (en) Confectionery
SG45099A1 (en) Composition
GB9508222D0 (en) Composition